TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25708562

Group type: EXPERIMENTAL
Intervention: Low ligation of the inferior mesenteric artery with apical lymph node dissection
Number of subjects: 57

Group type: COMPARATOR
Intervention: High ligation of the inferior mesenteric artery
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Low ligation with apical lymph node dissection
Number of subjects: 57

Group type: COMPARATOR
Intervention: High ligation
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Anastomotic leakage
Number of subjects: 57
Study: 25854015

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Western medication (Fluoxetine)
Number of subjects: 80
Study: 22827882

Group type: EXPERIMENTAL
Intervention: Hydrophilic catheter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polyvinyl chloride catheter
Number of subjects: 0
Study: 21454742

Group type: EXPERIMENTAL
Intervention: rhBMP-2/ACS (1.5 mg/mL, total 12.0 mg)
Number of subjects: 277

Group type: COMPARATOR
Intervention: SOC (standard of care)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: rhBMP-2/ACS
Number of subjects: 277

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 277
Study: 19428843

Group type: EXPERIMENTAL
Intervention: PCV9
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCV9 alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hib‐PCV9‐MnCC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCV9, PCV9‐MnCC, Hib‐PCV9‐MnCC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interactions of PCV9, MnCC and Hib
Number of subjects: 0
Study: 16800837

Group type: EXPERIMENTAL
Intervention: Once-monthly ibandronate plus patient support programme (PSP)
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Once-weekly alendronate
Number of subjects: 1054
Study: 15090625

Group type: COMPARATOR
Intervention: Standard diet (400 to 500 mg of dietary calcium/d supplemented with placebo)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-calcium diet (standard diet supplemented with 800 mg of calcium/d)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-dairy diet (1200 to 1300 mg of dietary calcium/d supplemented with placebo)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-calcium diet
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-dairy diet
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low-calcium diet
Number of subjects: 32
Study: 11003743

Group type: EXPERIMENTAL
Intervention: Leukocyte filtration using Pall BC1B filter (group F, 15 patients)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Dummy filters (group C, 17 patients)
Number of subjects: 32
Study: 9380804

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (M1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Two injections of three insulins (M2)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Euclamin 20 mg + intermediate insulin (M3)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Euclamine 20 mg + intermediate insulin (M4)
Number of subjects: 27
Study: 8453961

Group type: EXPERIMENTAL
Intervention: rac-felodipine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: rac-nitrendipine
Number of subjects: 12

Group type: COMPARATOR
Intervention: nifedipine
Number of subjects: 12
Study: 3792524

Group type: EXPERIMENTAL
Intervention: Family support services (special counseling sessions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Periodic support services (follow-up phone calls)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular clinic services (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Special support services (combined)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cumulative pregnancy rate
Number of subjects: 0
Study: 31346789

Group type: EXPERIMENTAL
Intervention: Football training and dietary advice (FD)
Number of subjects: 50
Study: 28766976

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 2840

Group type: COMPARATOR
Intervention: Alternative treatments
Number of subjects: 2840
Study: 27366831

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-scopolamine response in MDD patients
Number of subjects: 0
Study: 24770471

Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sensorimotor training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 21992869

Group type: EXPERIMENTAL
Intervention: Brief telephone intervention plus treatment as usual
Number of subjects: 62

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 62
Study: 20890622

Group type: EXPERIMENTAL
Intervention: Family Talk Intervention (FTI)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Let's Talk about the Children (LT)
Number of subjects: 149
Study: 17126974

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fluphenazine (6-21 mg/day)
Number of subjects: 22
Study: 16375203

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg, 3 times daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12015629

Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution (46 +/- 1 g) during the run (M+C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water during the run (M + W)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution (M+C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water (M + W)
Number of subjects: 8
Study: 9801011

Group type: EXPERIMENTAL
Intervention: Smoking intervention
Number of subjects: 5887
Study: 7642836

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.3 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.6 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.9 mg/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 2666335

Group type: EXPERIMENTAL
Intervention: Intravenous (I.V.) metronidazole
Number of subjects: 154

Group type: COMPARATOR
Intervention: Intravenous (I.V.) metronidazole-gentamicin-ampicillin
Number of subjects: 154
Study: 812456

Group type: EXPERIMENTAL
Intervention: Immediate postoperative parenteral hyperalimentation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study: 31520209

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT) with a 50-kV x-ray
Number of subjects: 434

Group type: COMPARATOR
Intervention: IORT cancellation
Number of subjects: 434
Study: 26846656

Group type: EXPERIMENTAL
Intervention: Flexion gap exceeded extension gap by 2.5 mm (Group 1)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Flexion gap equal to extension gap (Group 2)
Number of subjects: 404
Study: 25400202

Group type: EXPERIMENTAL
Intervention: Changing the task from a category-learning task to choosing the 'winning' object in each stimulus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 'Who's winning' effect
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intersection discovery process
Number of subjects: 0
Study: 23395257

Group type: EXPERIMENTAL
Intervention: Alfacalcidol 0.25 μg twice daily
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 21434783

Group type: EXPERIMENTAL
Intervention: Randomized group (RHA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Preference group (RHA)
Number of subjects: 50
Study: 18607835

Group type: EXPERIMENTAL
Intervention: Pellicle-covered samples
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pellicle-free samples (Control)
Number of subjects: 10
Study: 15780700

Group type: EXPERIMENTAL
Intervention: Substance comorbidity
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Anxiety comorbidity
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Combined comorbidity
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: PTSD due to non-combat stressors
Number of subjects: 328
Study: 11880840

Group type: EXPERIMENTAL
Intervention: Spinal morphine 20 microgram/kg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Spinal morphine 10 microgram/kg
Number of subjects: 65

Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 65
Study: 10447232

Group type: EXPERIMENTAL
Intervention: Intense lifestyle intervention (low-fat, high-fibre diet and regular physical exercise, one-month learning and training session)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Intense lifestyle intervention
Number of subjects: 186

Group type: COMPARATOR
Intervention: Usual care (one-hour counselling session with a specially trained nurse)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 186
Study: 7604646

Group type: EXPERIMENTAL
Intervention: 10 mg/d cetirizine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 20 mg/d cetirizine
Number of subjects: 24

Group type: COMPARATOR
Intervention: cetirizine (10 mg/d or 20 mg/d)
Number of subjects: 24
Study: 2672989

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% (1 ml/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% or 0.5% (Age (years +2)/10 ml per dermatome)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 384858

Group type: EXPERIMENTAL
Intervention: 10 days of treatment with trimethoprim/sulfamethoxazole
Number of subjects: 38

Group type: COMPARATOR
Intervention: 12 weeks of treatment with trimethoprim/sulfamethoxazole
Number of subjects: 38
Study: 30967640

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN) 3 hours after LCBDE
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional management with regular diet when tolerated (Control group)
Number of subjects: 100
Study: 26606421

Group type: COMPARATOR
Intervention: Community-based intervention
Number of subjects: 5879

Group type: COMPARATOR
Intervention: Higher level of education
Number of subjects: 5879

Group type: EXPERIMENTAL
Intervention: Waist-to-height ratio
Number of subjects: 5879

Group type: EXPERIMENTAL
Intervention: Being divorced/widowed compared with married
Number of subjects: 5879

Group type: EXPERIMENTAL
Intervention: Hip circumference
Number of subjects: 5879

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 5879
Study: 26001844

Group type: EXPERIMENTAL
Intervention: Lifestyle coaching plus care coordination
Number of subjects: 450

Group type: COMPARATOR
Intervention: Care coordination alone
Number of subjects: 450

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 450
Study: 23637831

Group type: EXPERIMENTAL
Intervention: Fruit juice consumption
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Fruit juice consumption in low-median intake of total polyphenols
Number of subjects: 618
Study: 21263010

Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Reboxetine (NARI)
Number of subjects: 601
Study: 19737501

Group type: EXPERIMENTAL
Intervention: Alcohol consumption with nonprimary partners
Number of subjects: 1419

Group type: EXPERIMENTAL
Intervention: Alcohol consumption with primary partners
Number of subjects: 1419

Group type: EXPERIMENTAL
Intervention: Partner substance use (both partners drinking)
Number of subjects: 1419
Study: 16280464

Group type: EXPERIMENTAL
Intervention: Tinnitus sufferers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 15262734

Group type: EXPERIMENTAL
Intervention: Pramipexole 0.5 mg 3 times per day with levodopa placebo (n = 151)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Levodopa 25/100 mg carbidopa/levodopa 3 times per day with pramipexole placebo (n = 150)
Number of subjects: 301
Study: 11959050

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study: 10346418

Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms twice daily
Number of subjects: 482

Group type: COMPARATOR
Intervention: Salmeterol 50 micrograms
Number of subjects: 482
Study: 7621634

Group type: EXPERIMENTAL
Intervention: 18 g human intravenous immunoglobulin (IVIg) every three weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Human albumin placebo every three weeks
Number of subjects: 42
Study: 2238755

Group type: EXPERIMENTAL
Intervention: Pancreatin (6 x 2 capsules, 6 x 300 mg/d)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 347878

Group type: EXPERIMENTAL
Intervention: Bromperidol
Number of subjects: 25
Study: 30224341

Group type: COMPARATOR
Intervention: FOLFIRI-Bevacizumab
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: mFOLFOX6-Bevacizumab
Number of subjects: 376

Group type: COMPARATOR
Intervention: High plasma VEGF-A levels (>5.1 pg/mL)
Number of subjects: 376
Study: 27939574

Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg capsule orally, 1 hour before surgery and 75 mg twice a day for 2 days postoperatively)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (2 similar-looking multivitamin capsules)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study: 25879524

Group type: EXPERIMENTAL
Intervention: olmesartan/amlodipine/hydrochlorothiazide (OLM/AML/HCTZ)
Number of subjects: 2690
Study: 22554293

Group type: EXPERIMENTAL
Intervention: 1% alendronate gel
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 69
Study: 21317170

Group type: COMPARATOR
Intervention: teduglutide 0.10 mg/kg/day
Number of subjects: 83

Group type: COMPARATOR
Intervention: teduglutide 0.05 mg/kg/day
Number of subjects: 83

Group type: COMPARATOR
Intervention: teduglutide (both doses)
Number of subjects: 83

Group type: COMPARATOR
Intervention: teduglutide
Number of subjects: 83
Study: 19592279

Group type: EXPERIMENTAL
Intervention: High levels of depressive symptoms
Number of subjects: 572

Group type: COMPARATOR
Intervention: Locus of control
Number of subjects: 572
Study: 18705947

Group type: EXPERIMENTAL
Intervention: High-dose human albumin (2 g/kg) administered in a 2-hour intravenous infusion within 5 hours of symptom onset
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: High-dose human albumin (2 g/kg)
Number of subjects: 1800
Study: 15499139

Group type: EXPERIMENTAL
Intervention: Anaesthetic rebreathing circuit
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ventilator with volume guarantee
Number of subjects: 24
Study: 11451176

Group type: EXPERIMENTAL
Intervention: Induction treatment (daily dose of interferon) with ribavirin 1,000-1,200 mg
Number of subjects: 244

Group type: COMPARATOR
Intervention: Standard treatment (interferon thrice weekly) with ribavirin 1,000-1,200 mg
Number of subjects: 244
Study: 9592045

Group type: EXPERIMENTAL
Intervention: GDNF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ret
Number of subjects: 0
Study: 8152279

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon (IFN) based treatment regimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemotherapy or IFN-monotherapy
Number of subjects: 0
Study: 3043692

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 64
Study: 29680338

Group type: EXPERIMENTAL
Intervention: CAD Consortium clinical score (CAD2)
Number of subjects: 1738

Group type: EXPERIMENTAL
Intervention: Updated Diamond-Forrester score (UDF)
Number of subjects: 1738

Group type: EXPERIMENTAL
Intervention: CONFIRM risk score (CRS)
Number of subjects: 1738
Study: 27925849

Group type: EXPERIMENTAL
Intervention: Pediatric emergency ruler (PaedER)
Number of subjects: 150
Study: 27547925

Group type: EXPERIMENTAL
Intervention: Donor fecal microbiota transplantation (FMT) administered by colonoscopy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Autologous fecal microbiota transplantation (FMT) administered by colonoscopy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Autologous FMT by site
Number of subjects: 46
Study: 24150784

Group type: EXPERIMENTAL
Intervention: Acute passive vibration (PV) at 25 Hz and 2 mm amplitude
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no-PV)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Acute passive vibration (PV)
Number of subjects: 11
Study: 22716974

Group type: EXPERIMENTAL
Intervention: Midurethral sling
Number of subjects: 337

Group type: COMPARATOR
Intervention: Sham incisions
Number of subjects: 337
Study: 19342023

Group type: EXPERIMENTAL
Intervention: rFSH plus finasteride
Number of subjects: 36

Group type: COMPARATOR
Intervention: rFSH alone
Number of subjects: 36
Study: 17355994

Group type: EXPERIMENTAL
Intervention: Tailored advice on strength and balance training (SBT) activities, n = 144
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group receiving all advice without tailoring, n = 136
Number of subjects: 280
Study: 16373948

Group type: EXPERIMENTAL
Intervention: Egg breakfast
Number of subjects: 30
Study: 11921013

Group type: EXPERIMENTAL
Intervention: Combined modality treatment for limited stage Hodgkin's lymphoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABVD regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future studies
Number of subjects: 0
Study: 10663896

Group type: EXPERIMENTAL
Intervention: Biofragmentable anastomosis ring (BAR)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Stapled anastomosis
Number of subjects: 36
Study: 7571984

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of AT III (two different dosages)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 2193613

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study: 389148

Group type: EXPERIMENTAL
Intervention: EMG feedback therapy
Number of subjects: 28
Study: 30916742

Group type: EXPERIMENTAL
Intervention: Surgery plus Extensive Intraoperative Peritoneal Lavage (EIPL)
Number of subjects: 662

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 662
Study: 30360531

Group type: EXPERIMENTAL
Intervention: Preoperative paravertebral block (PVB) with bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Postoperative paravertebral block (PVB) with bupivacaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no PVB)
Number of subjects: 90
Study: 26661685

Group type: EXPERIMENTAL
Intervention: Extra virgin coconut oil (EVCO)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil (EVOO)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Rice bran oil (RBO)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Butter (control)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Health benefit statement for oils
Number of subjects: 148
Study: 24767009

Group type: EXPERIMENTAL
Intervention: Internet-based trauma-focused cognitive behavioural therapy with exposure components
Number of subjects: 125

Group type: COMPARATOR
Intervention: Internet-based trauma-focused cognitive behavioural therapy without exposure components
Number of subjects: 125
Study: 23132187

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Reading control condition
Number of subjects: 64
Study: 20708444

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 17403002

Group type: EXPERIMENTAL
Intervention: Intensive medical therapy (IMT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IMT (with or without psychological interventions)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IMT plus psychological interventions (IMT-MR or IMT-CBT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IMT-CBT
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 100
Study: 17998645

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy with or without chemotherapy
Number of subjects: 178
Study: 17476649

Group type: EXPERIMENTAL
Intervention: Psychological interventions (specific details not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instrumental variable (IV) methods for estimation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three two-stage estimation procedures
Number of subjects: 0
Study: 10627102

Group type: EXPERIMENTAL
Intervention: Self-service sales of beer, wine, and spirits
Number of subjects: 14

Group type: COMPARATOR
Intervention: Over-the-counter sales
Number of subjects: 14
Study: 8791966

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg b.d.
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg q.d.s.
Number of subjects: 772
Study: 1537516

Group type: EXPERIMENTAL
Intervention: Lentils (premeal)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Bread (premeal)
Number of subjects: 17
Study: 6332454

Group type: EXPERIMENTAL
Intervention: TTS scopolamine (5 micrograms/h)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: dimenhydrinate (100 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 16
Study: 30954338

Group type: EXPERIMENTAL
Intervention: IV and topical tranexamic acid (TXA)
Number of subjects: 57

Group type: COMPARATOR
Intervention: IV tranexamic acid (TXA)
Number of subjects: 57
Study: 29638090

Group type: EXPERIMENTAL
Intervention: Uncovered self‐expanding metal stents (SEMS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Plastic biliary stents
Number of subjects: 40
Study: 26616409

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (3 mg/kg/twice a day of zinc sulfate monohydrate orally for 10 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard antibiotic treatment without zinc (Control)
Number of subjects: 0
Study: 23625127

Group type: EXPERIMENTAL
Intervention: SystemCHANGE™‐HIV intervention
Number of subjects: 0
Study: 22702146

Group type: EXPERIMENTAL
Intervention: Combined spinal anesthesia (2nd group)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combined epidural anesthesia (3rd group)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combined spinal‐epidural anesthesia (4th group)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Traditional endotracheal anesthesia (1st group)
Number of subjects: 61